Doctor: I Can Synthesize Infinite Entries

Chapter 338: Chapter 230: Another Trump Card

Only then did he realize how reassuring it was to work with such an all-around emergency physician.

”I’ll be the lead surgeon for the cardiac stent procedure. After that, we’ll wait for Director Qiao to take over for the subsequent steps.”

”I’ve only studied emergency procedures, so I don’t have a comprehensive grasp of the follow-up operations. But I can definitely buy Director Qiao enough time.”

With Wu Ting stepping up, the surgery on President Liang began swiftly.

Luo Ming stayed behind, watching Wu Ting and Dr. Huang enter the operating room, filled with emotion.

’Director Wu is truly in a league of his own.’

’It hasn’t been long since he went to Jinggang University Affiliated First Hospital for advanced training in cardiac surgery. Not only did he earn his postgraduate degree, but he’s also mastered so many cardiac procedures.’

Luo Ming knew that if he went into the operating room, he could only stand by and cheer; he wouldn’t even understand what Director Wu was doing. So, he simply returned to his post.

As time went on, Luo Ming had come to accept the fact that the gap between ordinary workhorses like him and Director Wu would only continue to widen.

However, having briefly been Director Wu’s attending physician for a few days in his career was still something to brag about.

Inside the operating room.

Wu Ting began the cardiac stent procedure. Modern cardiac stents are typically made of metal or plastic. They are inserted into a diseased coronary artery to support the vessel wall and maintain smooth blood flow through the lumen.

However, metal or plastic stents have significant drawbacks. They do not fully endothelialize, can cause abnormal vasodilation and vasoconstriction in the stented segment, and their non-bioresorbable nature leads to chronic inflammation. Over time, this inevitably results in late-stage in-stent thrombosis, restenosis, or even complete occlusion. These issues represent an unresolved risk and a major pain point for current cardiac stent technology.

This was also one of the key reasons why Lou Musaang could not undergo a stent procedure. Her unique constitution made her more prone to in-stent thrombosis, leading to restenosis and occlusion, than the average person.

For President Liang, they were using the most classic type of metal stent.

After the anesthesiologist administered general anesthesia to the patient,

Wu Ting began the first step with practiced skill, using the patient’s right femoral artery as the primary access point...

”22-French long guide sheath... Administer 5,000 units of heparin into the artery...”

Simultaneously, he punctured the patient’s left femoral artery to create a secondary access point...

Watching Wu Ting’s technique, Dr. Huang’s eyes lit up. ’This Dr. Wu is truly incredible!’

His movements, the precise control of force—it was all even more deft than Director Qiao’s.

”Aortic root angiography...”

”AL2 catheter with a straight-tip, ultra-smooth guidewire to cross the valve...”

”S-model pre-shaped Angelguide workhorse guidewire...”

Under Wu Ting’s calm direction, Dr. Huang assisted with ease.

Soon, Wu Ting, assisted by Dr. Huang, had finished inserting the catheter.

”Balloon...”

Wu Ting continued to control the pace, using an inflatable balloon to expand the narrowed section!

Next came the most critical step: using the delivery system to guide the arterial stent to the correct position...

This step was a true test of the lead surgeon’s control over force, angle, and their understanding of arterial anatomy.

Just as Wu Ting was performing this step, Director Qiao arrived at the operating room.

He took in every one of Wu Ting’s movements.

’This Wu Ting is that good?’

Director Qiao had been worried. After all, he was the only one in the entire City First Hospital who could perform cardiac stent procedures. He never expected that Director Wu from the Emergency Department, who was currently all the rage, could complete it so effortlessly.

That’s right. In Director Qiao’s eyes, Wu Ting’s technique had transcended mere mundane proficiency and reached a breathtaking, artistic level.

Director Qiao had to admit that when it came to this cardiac stent procedure, Wu Ting was far superior to him.

This level of skill was at least on par with a chief physician from a top provincial hospital.

’No wonder the hospital invested so heavily, building an entire liver tumor experimental building just for Director Wu. His reputation is well-deserved.’

Seeing that Wu Ting was as steady as a rock, Director Qiao decided to keep quiet and just wait.

The Cardiothoracic Surgery Department at City First Hospital was a marginal department to begin with, one that was pushed into existence just to meet the requirements for a comprehensive Grade A Tertiary hospital.

He, Director Qiao, wasn’t particularly ambitious to begin with, so he was naturally won over by Wu Ting’s genuine skill. But even if Wu Ting did nothing, his special status at City First Hospital meant he wasn’t someone a department director like him could afford to offend.

On the operating table, Wu Ting precisely implanted the stent into the now-expanded narrow section of the artery, preventing it from recoiling.

Afterward, Wu Ting flawlessly withdrew all the catheters, leaving the arterial stent firmly in place within the dilated arterial stenosis!

At this point, Wu Ting had completed the stent placement, finishing the most critical part of the surgery. All that remained were the follow-up procedures.

Wu Ting had also noticed Director Qiao’s arrival. He politely gave up the lead surgeon’s position and even yielded the first assistant’s spot to Dr. Huang, moving himself to the very back.

”Director Qiao, Dr. Huang, I’ll leave the rest of the treatment to you. I’m not too familiar with the subsequent procedures.”

Wu Ting was so sincere and humble that Director Qiao and Dr. Huang, for some reason, felt both flattered and a little overwhelmed.

”Alright, thank you for your hard work, Director Wu. Leave the rest to us.”

Director Qiao focused his attention and began the subsequent procedures with Dr. Huang.

With the solid foundation Wu Ting had laid, the rest of the surgery went very smoothly. President Liang was temporarily out of danger.

The reason it was ”temporary” was that they still hadn’t found the cause of President Liang’s sudden acute myocardial infarction.

[Ding! Congratulations, Host, for leading Dr. Huang of the Cardiothoracic Surgery Department in completing a cardiac stent procedure. You have earned the sincere admiration and appreciation of Director Qiao and Director Huang. At the same time, you have rescued a top chief engineer in the domestic new materials R&D field. You have acquired the patient Liang Kangjun’s entry: Bioresorbable Polymer Technology (Purple), the most promising bioresorbable polymer technology.]

[Note: This technology allows for the synthesis of polymers and copolymers from the lactide, glycolide, and caprolactone families, such as poly-L-lactic acid (PLLA), poly-D-lactic acid (PDLA), poly-D,L-lactic acid (PDLLA), poly-ε-caprolactone (PCL), and tyrosine-derived polycarbonate polymers (PTD-PC), etc.]

[Does the Host wish to synthesize the entries: Bioresorbable Polymer Technology (Purple) + Stent Technology (Purple) = Bioresorbable Stent Technology (Purple), a new, era-defining biodegradable polymer stent technology?]

[Note: This technology will officially raise the curtain on the era of absorbable polymer stents! It has vast potential and can completely eliminate the complications of traditional metal stents, resolving a series of physiological reactions such as thrombosis, inflammation, and cell proliferation and migration.]

[Note: The most outstanding advantage of this bioresorbable stent is its ability to restore the normal structure and physiological function of the blood vessel. It is automatically absorbed and disappears after completing its functions of preventing negative vascular remodeling and releasing drugs. Compared to metal stents, absorbable polymer stents have higher compliance, can potentially eliminate chronic inflammatory reactions, and promote positive vascular remodeling.]

[Note: This is another brand-new product capable of generating staggering revenue—a brilliant product that will make pharmaceutical companies like Pfizer and Johnson & Johnson pale in comparison.]

Looking at this entry, Wu Ting felt a surge of ecstasy.

This was truly a double blessing! Not only could he try to solve Lou Musaang’s congenital heart disease, but he would also have another unexpected trump card to play in the upcoming confrontation with Pfizer!

After the surgery was complete, everyone walked out of the operating room.

Next, Wu Ting, Director Qiao, and Dr. Huang had another important task: to find the culprit behind President Liang’s sudden acute myocardial infarction.

If they couldn’t find the pathogenic cause, the underlying risk would remain.

Under normal circumstances, given President Liang’s physical condition, he shouldn’t have suffered such an acute, sudden myocardial infarction.

The three of them began to slowly investigate the possibilities.

As he looked through the records, Wu Ting once again noticed the patient’s medical history. He also had liver cancer and had undergone transcatheter arterial chemoembolization combined with antiviral therapy, administered by Director Zhang Heng.

The first time might have been a coincidence, but encountering this situation a second time was enough to grab Wu Ting’s full attention.